AIDS and Behavior

, Volume 6, Issue 2, pp 153–162 | Cite as

Comparison of General and Detailed HIV Risk Assessments Among Methamphetamine Abusers

  • Geoffrey R. Twitchell
  • Alice Huber
  • Cathy J. Reback
  • Steven Shoptaw


Investigators have long focused on refining the accuracy of HIV risk assessment. One concern is that HIV risk measures either cover general risk behaviors or assess a few specific behaviors. We compared a standardized general measure (Risk for AIDS Behavior, RAB) and a recently developed behaviorally detailed measure (Behavioral Questionnaire-Amphetamine, BQA) in three samples of methamphetamine-dependent individuals in drug treatment in Southern California (76 gay men, 57 heterosexual men, and 33 heterosexual women). Our results indicate that RAB depicted gay men at significantly higher risk than either heterosexual men or women. However, RAB Total score failed to discriminate between HIV-infected and HIV-uninfected gay men. By contrast, BQA discriminated between HIV-infected and HIV-uninfected men as measured by significantly more instances of unprotected anal receptive intercourse. General measures, e.g., RAB, may have utility for describing broad risk factors across heterogeneous groups of substance users. More detailed measures, e.g., BQA, may be necessary for distinguishing behavioral risk differences within high-risk populations such as substance-abusing gay men.

Risk factors sexual behavior methamphetamine homosexual men drug users behavioral interventions 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Allen, D. M., Onorato, I. M., and Green, T. A. (1992). HIV infection in intravenous drug users entering drug treatment, United States, 1988 to 1989. The Field Services Branch of the Centers for Disease Control. American Journal of Public Health, 82, 541-546.Google Scholar
  2. Anglin, M. D., Kalechstein, A., Maglione, M., Annon, J., and Fiorentine, R. (1997). Methamphetamine abuse and treatment in California:Aregional report. Los Angeles, CA: UCLA Research Center.Google Scholar
  3. Annon, J., Longshore, D., Rawson, R., and Anglin, M. D. (2000). LAAM and methadone maintenance treatment; retention, drug use, and HIV risk behaviors. Presented at the 62nd Annual Scientific Meeting of the College on Problems of Drug Dependence, San Juan, Puerto Rico.Google Scholar
  4. Battjes, R. J., Pickens, R. W., and Brown, L. S. (1995). HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment-An update. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10, 90-96.Google Scholar
  5. Booth, R. E., Kwiatkowski, C. F., and Stephens, R. C. (1998). Effectiveness of HIV/AIDS interventions on drug use and needle risk behaviors for out-of-treatment injection drug users. Journal of Psychoactive Drugs, 30, 269-278.Google Scholar
  6. Catania, J. A., Gibson, D. R., Chitwood, D. D., and Coates, T. J. (1990). Methodological problems in AIDS behavioral research: Influences on measurement error and participation bias in studies of sexual behavior. Psychological Bulletin, 108, 339-362.Google Scholar
  7. Chawarski, M. C., Pakes, J., and Schottenfeld, R. S. (1998). Assessment of HIV risk. Journal of Addictive Diseases, 17, 49-59.Google Scholar
  8. Chesney, M. A., Chambers, D. B., and Kahn, J. O. (1997). Risk behavior for HIV infection in participants in preventive HIV vaccine trials: A cautionary note. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 16, 266-271.Google Scholar
  9. Cunningham, J. K., and Thielemier, M. A. (1995). Trends and regional variations in amphetamine-related emergency admissions: California, 1984-1993. Irvine, CA: Public Statistics Institute.Google Scholar
  10. Deren, S., Estrada, A., Stark, M., Williams, M., and Goldstein, M. (1997). A multisite study of sexual orientation and injection drug use as predictors of HIV serostatus in out-of-treatment male drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 15, 289-295.Google Scholar
  11. DiFranceisco, W., McAuliffe, T. L., and Sikkema, K. J. (1998). Influences of survey instrument format and social desirability on the reliability of self-reported high risk sexual behavior. AIDS and Behavior, 2, 329-337.Google Scholar
  12. Dillon, B., Hecht, F. M., Swanson, M., Goupil-Sormany, I., Grant, R. M., Chesney, M. A., and Kahn, J. O. (2000). Primary HIV infections associated with oral transmission. Presented at the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, California.Google Scholar
  13. Frosch, D., Shoptaw, S., Huber, A., and Rawson, R. A. (1996). Sexual HIV risk among gay and bisexual male methamphetamine abusers. Journal of Substance Abuse Treatment, 13, 483-486.Google Scholar
  14. Greenfield, L., Bigelow, G. E., and Brooner, R. K. (1995). Validity of intravenous drug abusers' self-reported changes in HIV high risk drug use behaviors. Drug and Alcohol Dependence, 39, 91-98.Google Scholar
  15. HIV Epidemiology Program, Los Angeles County Department of Health Services (2000, 15 October). Advanced HIV Disease (AIDS) Surveillance Summary 1-26.Google Scholar
  16. Holmberg, S.D. (1996). The estimated prevalence and incidence of HIV in 96 large U.S. metropolitan areas. American Journal of Public Health, 86, 642-654.Google Scholar
  17. Hunter, G. M., Donoghoe, M. C., Stimson, G. V., and Rhodes, T. (1995). Changes in the injecting risk behaviour of injecting drug users in London, 1990-1993. AIDS, 9, 493-501.Google Scholar
  18. Iguchi, M. Y., Platt, J. J., French, J., Baxter, R. C., Kushner, H., Lidz, V. M., Bux, D. A., Rosen, M., and Musikoff, H. (1992). Correlates of HIV seropositivity among injection drug users not in treatment. Journal of Drug Issues, 22, 849-866.Google Scholar
  19. Iguchi, M. Y., Bux, D. A., Lidz, V., Kushner, H., French, T. F., and Platt, J. J. (1994). Interpreting HIV seroprevalence data from a street-based outreach program. Journal of Acquired Immune Deficiency Syndromes, 7, 491-499.Google Scholar
  20. Leigh, B. C., and Stall, R. (1993). Substance use and risky sexual behavior for exposure to HIV: Issues in methodology, interpretation, and prevention. American Psychologist, 48, 1035-1045.Google Scholar
  21. Longshore, D., Anglin, M. D., Annon, K., and Hsieh, S. C. (1993). Trends in self-reported HIV risk behavior-Injection drug users in Los Angeles. Journal of Acquired Immune Deficiency Syndromes, 6, 82-90.Google Scholar
  22. Metzger, D. S., DePhilippis, D., Druley, P., O'Brien, C. P., McLellan, A., Williams, J., Navaline, H., Dyanick, S., and Woody, G. E. (1991). The impact of HIV testing on risk for AIDS behaviors. Presented at the 53rd Annual Scientific Meeting of the College on Problems of Drug Dependence, Palm Beach, Florida.Google Scholar
  23. Metzger, D. S., Woody, G. E., McLellan, A. T., O'Brien, C. P., Druley, P., Navaline, H., DePhilippis, D., Stolley, P., and Abrutyn, E. (1993). Human immunodeficiency virus seroconversion among intravenous drug users in-and out-of treatment: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 6, 1049-1056.Google Scholar
  24. Molitor, F., Truax, S. R., Ruiz, J. D., and Sun, R. K. (1998). Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. Western Journal of Medicine, 168, 93-97.Google Scholar
  25. Molitor, F., Ruiz, J. D., Flynn, N., Mikanda, J. N., Sun, R. K., and Anderson, R. (1999). Methamphetamine use and sexual and injection risk behaviorsamongout-of-treatment injection drug users. American Journal of Drug and Alcohol Abuse, 25, 475-493.Google Scholar
  26. Moss, A. R., Vranizan, K., Gorter, R., Bacchetti, P., Watters, J., and Osmond, D. (1994). HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS, 8, 223-231.Google Scholar
  27. Navaline, H. A., Snider, E. C., Petro, C. J., Tobin, D., Metzger, D., Alterman, A. I., and Woody, G. E. (1994). Preparations for AIDS vaccine trials. An automated version of the Risk Assessment Battery (RAB): Enhancing the assessment of risk behaviors. AIDS Research on Human Retroviruses, 10, S281-S283.Google Scholar
  28. Paul, J. P., Stall, R. D., Crosby, G. M., and Barrett, D. C. (1994). Correlates of sexual risk-taking among gay male substance abusers. Addiction, 89, 971-983.Google Scholar
  29. Reback, C. J. (1997). The social construction of a gay drug: Methamphetamine use among gay and bisexual males in Los Angeles. Report for the City of Los Angeles, AIDS Coordinator.Google Scholar
  30. Reback, C. J., and Grella, C. E. (1999). HIV risk behaviors of gay and bisexual male methamphetamine users contacted through Street Outreach. Journal of Drug Issues, 29, 155-166.Google Scholar
  31. Shoptaw, S., Reback, C. J., Frosch, D. L., and Rawson, R. A. (1998). Stimulant abuse treatment as HIV prevention. Journal of Addictive Diseases, 17, 19-32.Google Scholar
  32. Shoptaw, S., Reback, C. J., and Freese, T. E. (2002). Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles. Journal of Addictive Diseases, 21, 91-106.Google Scholar
  33. Sorensen, J. L., and Copeland, A. L. (2000). treatment as an HIV prevention strategy: A review. Drug and Alcohol Dependence, 59, 17-31.Google Scholar
  34. Stall, R., and Leigh, B. (1994). Understanding the relationship between drug or alcohol use and high risk sexual activity for HIV transmission: Where do we go from here? Addiction, 89, 131-134.Google Scholar
  35. Stall, R., and Purcell, D. W. (2000). Intertwining epidemics: A review of research on substance use among men who have sex with men and its connection to the AIDS epidemic. AIDS and Behavior, 4, 181-192.Google Scholar
  36. Watters, J. K. (1994). Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986-1992. Journal of Acquired Immune Deficiency Syndromes, 7, 1276-1281.Google Scholar
  37. Wells, E. A., Clark, L. L., Calsyn, D. A., and Saxon, A. J. (1994). Reporting of HIV risk behaviors by injection drug using heterosexual couples in methadone maintenance. Drug and Alcohol Dependence, 36, 33-38.Google Scholar
  38. Williams, M. L., Freeman, R. C., Bowen, A. M., and Saunders, L. (1998). The acceptability of a computer HIV/AIDS risk assessment to not-in-treatment drug users. AIDS Care-Psychological and Socio-Medical Aspects of AIDS/HIV, 10, 701-711.Google Scholar

Copyright information

© Plenum Publishing Corporation 2002

Authors and Affiliations

  • Geoffrey R. Twitchell
    • 1
    • 2
  • Alice Huber
    • 1
  • Cathy J. Reback
    • 1
    • 3
  • Steven Shoptaw
    • 1
  1. 1.UCLA Integrated Substance Abuse Programs (UCLA ISAP)Los Angeles
  2. 2.Friends Research InstituteLos Angeles
  3. 3.Van Ness Recovery HouseLos Angeles

Personalised recommendations